There are currently 17 active clinical trials seeking participants for Cardiovascular Risk Factor research studies. The states with the highest number of trials for Cardiovascular Risk Factor participants are California, Ontario, Texas and Pennsylvania.
Mechanisms Underlying the Protective Vascular Effects of Dietary Potassium in Humans
Recruiting
Americans continue to consume high amounts of sodium. Potassium is notable for its blood pressure lowering effects but less is known regarding its effect on the vasculature. This investigation seeks to determine the role of dietary potassium on the vasculature in the presence of a high sodium diet in salt-resistant adults.
Gender:
All
Ages:
Between 18 years and 45 years
Trial Updated:
05/30/2023
Locations: University of Delaware, Newark, Delaware
Conditions: Cardiovascular Risk Factor
The Potassium Supplementation Study
Recruiting
This study will test whether potassium supplementation can reduce the deleterious effect of a high sodium diet on blood vessel function, blood pressure reactivity and autonomic nervous system function in apparently healthy adults.
Gender:
All
Ages:
Between 18 years and 45 years
Trial Updated:
05/30/2023
Locations: Tower at STAR, Newark, Delaware
Conditions: Cardiovascular Health, Cardiovascular Risk Factor
Effects of Obesity and Intensity of Exercise on Ghrelin Levels
Recruiting
This study is investigating the effect of different intensities of exercise on levels of the hormone, ghrelin. In addition, we will be examining the relationship between any exercise induced changes in ghrelin and insulin sensitivity, obesity, and vascular function.
Gender:
All
Ages:
Between 18 years and 55 years
Trial Updated:
05/08/2023
Locations: University of Virginia, Charlottesville, Virginia
Conditions: Obesity, Insulin Resistance, Cardiovascular Risk Factor
Effects of Nitric Oxide on the Endothelium During Hemolysis.
Recruiting
This study is an ancillary (add-on) study to the clinical trial entitled "Effect of Nitric Oxide in Cardiac Surgery Patients With Endothelial Dysfunction", which has Clinical Trials.gov identifier NCT02836899. NCT02836899 trial randomizes cardiac surgical patients to receive either Nitric Oxide (NO) or a placebo during and after cardiac surgery. This ancillary study aims to assess the effects of Nitric Oxide on vascular responsiveness and on endothelial function during hemolysis in patients wit... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
11/08/2022
Locations: Massachusetts General Hospital, Boston, Massachusetts +1 locations
Conditions: Endothelial Dysfunction, Hemolysis Intravascular, Cardiovascular Diseases, Cardiovascular Risk Factor
Sleep Duration and Cardiovascular Health
Recruiting
This is a cross-sectional study with an optional intervention that will examine how extreme sleep durations relate to cardiovascular health, physical activity, and sleep quality by studying three groups of participants: short sleepers (≤ 6 hrs), long sleepers (≥ 9 hrs), and average duration sleepers (7-8 hrs). The optional intervention asks participants to maintain an 8-hour per night regular sleep schedule for one week.
Gender:
All
Ages:
Between 25 years and 65 years
Trial Updated:
08/10/2022
Locations: Oregon Health and Science University, Portland, Oregon
Conditions: Sleep, Cardiovascular Risk Factor